If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
58.50    0.00 (0.00%)
Bid:
58.00
Ask:
59.00
Spread: 1.00 (1.724%)
Market Cap: £51.52m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Notice of AGM

17 Jul 2023 07:00

RNS Number : 0648G
Calnex Solutions PLC
17 July 2023
Β 

17 July 2023

Calnex Solutions plc

("Calnex" or the "Company")

Notice of Annual General Meeting, Dividend timetable and posting of Annual Report

Calnex Solutions plc (AIM: CLX) provides test and measurement solutions for the global telecommunications sector and confirms that its Annual General Meeting ("AGM") will be held on 16 August 2023 at 9am at Oracle Campus, Linlithgow, EH49 7LR.

The Company's Annual Report and Accounts for the financial year ended 31 March 2023, along with the Notice of Annual General Meeting and a Form of Proxy, has been posted to shareholders and is available on the Company's website at: https://investors.calnexsol.com/.

AGM arrangements

The AGM will be held as a physical meeting, but the Company is pleased to offer the opportunity again for shareholders (or their duly appointed representatives and/or proxies) to participate remotely via Zoom, with the details of how to participate set out below. It would help the Company's planning if shareholders who wished to attend in person could email investors@calnexsol.com by no later than 5.30 p.m. on 1 August 2023 to confirm their wish to attend in order that the Company can be confident that the facilities proposed for the AGM will be able to accommodate attendance.

Details of any significant changes to the AGM arrangements will be published on the Company's website (https://investors.calnexsol.com/regulatory-news-alerts/) and shareholders are reminded that they can register for email alerts.

The Company is committed to encouraging shareholder engagement on the business of the AGM. As such, in addition to voting by proxy, shareholders (including any of their duly appointed proxies and/or corporate representatives) will be able to participate in the AGM by Zoom. Participating by Zoom will allow shareholders to view and listen to the AGM remotely and to follow the proceedings in real time as well as asking questions, if they are invited to do so. Please note, however, that shareholders will not be able to vote if participating by Zoom and it is therefore important that, if they wish to vote at the AGM, shareholders either physically attend the AGM or appoint a proxy to attend and vote on their behalf.

In order to participate by Zoom, shareholders will be required to pre-register by sending an email to investors@calnexsol.com by no later than 5.30 p.m. on 1 August 2023. Shareholders will then be sent by email a link to the Zoom meeting with detailed joining instructions.

The results of the voting will be available on the Company's website at https://investors.calnexsol.com/ as soon as practicable after the conclusion of the AGM.

Dividend timetable

As confirmed in the announcement of the Company's final results for the year ended 31 March 2023, released on 23 May 2023, the Company is proposing a final dividend of 0.62p per share. If approved by the passing of a resolution at the AGM, it is intended that the Dividend will be paid on 30 August 2023 to all shareholders on the register as at close of business on 28 July 2023, the record date.

Β 

For more information, please contact:

Β 

Calnex Solutions plc

Via Alma PR

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cenkos Securities plc - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

Β 

Alma PR

+ 44(0) 20 3405 0213

Caroline Forde, Hannah Campbell, Joe Pederzolli

Β 

Β 

Overview of Calnex

Β 

CalnexΒ designs, produces and markets test instrumentation and solutionsΒ for network synchronization and network emulation, enablingΒ its customers toΒ validateΒ the performance of the critical infrastructure associated withΒ telecomsΒ networks. To date,Β CalnexΒ has secured and delivered ordersΒ toΒ overΒ 600Β customer sites inΒ 68 countries across the world.Β Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Meta.

Β 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing worldwide distributionΒ capability.Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NOASFASWLEDSEIW
Date   Source Headline
10th Jun 20264:17 pmRNSLong-Term Incentive Plan Awards
1st Jun 20267:30 amRNSDirector Dealing
29th May 20263:00 pmRNSExercise of Options and Total Voting Rights
26th May 20267:00 amRNSFinal Results
14th May 20267:00 amRNSNotice of Presentations
13th Apr 20267:00 amRNSFY26 Trading Update and Notice of Results
30th Mar 20267:00 amRNSHolding(s) in Company
26th Nov 20257:30 amRNSDirector Dealing
18th Nov 20257:00 amRNSInterim Results
6th Nov 202511:30 amRNS-RCalnex and Viavi Partnership
30th Oct 20257:00 amRNSNotice of Results and Presentations
8th Oct 20252:08 pmRNSExercise of Options and Total Voting Rights
16th Sep 20259:09 amRNSExercise of Options and Total Voting Rights
14th Aug 20254:12 pmRNSResult of AGM
14th Aug 20257:00 amRNSAGM Statement
15th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
16th Jun 20259:52 amRNSLong-Term Incentive Plan Awards
10th Jun 202511:59 amRNSDirector Dealing
20th May 20257:00 amRNSFinal Results
15th May 20257:00 amRNSNotice of Investor Presentation
8th Apr 20257:00 amRNSFY25 Trading Update and Notice of Results
14th Mar 20257:00 amRNSDirector Dealing
29th Jan 202510:48 amRNSExercise of Options
19th Nov 20247:00 amRNSInterim Results
4th Nov 20247:00 amRNSNotice of Results and Investor Presentation
8th Oct 20247:00 amRNSDirector/PDMR Dealing
2nd Oct 20244:57 pmRNSResult of General Meeting
6th Sep 20247:00 amRNSNotice of General Meeting
22nd Aug 20245:18 pmRNSResult of AGM
22nd Aug 20247:00 amRNSAGM Statement
18th Jul 20249:08 amRNSNotice of AGM
17th Jul 20242:00 pmRNSLong-Term Incentive Plan Awards
21st May 20247:00 amRNSFY24 Final Results
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.